Dr. Michele Leann Renfrow is a Northridge, California based psychologist who is specialized in General Psychology. Her current practice location is 18549 Roscoe Blvd, Northridge. Patients can reach her at 818-996-1051. Dr. Michele Leann Renfrow is PSY.D. in General Psychology and her NPI number (Unique professional ID assigned by NPPES) is 1497888283. Dr. Michele Leann Renfrow is specialized in psychological testing and evaluating or assessing patient's personal characteristics, such as intelligence, personality, abilities, interests, aptitudes, and neuropsychological functioning. Accordingly, she performs counseling, psychoanalysis, psychotherapy, hypnosis, biofeedback, and behavior analysis and therapy. She can diagnose and treat mental and emotional disorder or disability, alcoholism and substance abuse, disorders of habit or conduct, as well as of the psychological aspects of physical illness, accident, injury, or disability by psycheducational evaluation, therapy, remediation, and consultation.
Complete Profile:
Dr. Michele Leann Renfrow speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1497888283
NPI Enumeration Date:
13 Mar, 2007
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Michele Leann Renfrow Po Box 113, Pasadena, California
Zip:
91102-0113
Patients can reach Dr. Michele Leann Renfrow at 18549 Roscoe Blvd, Northridge, California or can call to book an appointment on 818-996-1051.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.